Parsons Capital Management Inc. RI lowered its stake in CME Group Inc (NASDAQ:CME) by 5.2% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 10,949 shares of the financial services provider’s stock after selling 605 shares during the quarter. Parsons Capital Management Inc. RI’s holdings in CME Group were worth $2,125,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently added to or reduced their stakes in CME. Advantage Investment Management LLC boosted its stake in CME Group by 119.0% during the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock worth $36,000 after purchasing an additional 100 shares during the last quarter. Truvestments Capital LLC acquired a new stake in CME Group during the 1st quarter worth $32,000. Westside Investment Management Inc. acquired a new stake in CME Group during the 2nd quarter worth $38,000. Close Asset Management Ltd acquired a new stake in CME Group during the 1st quarter worth $34,000. Finally, Permanens Capital L.P. acquired a new stake in CME Group during the 1st quarter worth $41,000. 84.44% of the stock is currently owned by hedge funds and other institutional investors.

CME has been the topic of several recent research reports. ValuEngine raised shares of CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 8th. Citigroup set a $202.00 target price on shares of CME Group and gave the stock a “buy” rating in a research note on Thursday, May 2nd. Zacks Investment Research cut shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 target price on the stock. in a research note on Monday, May 27th. UBS Group lifted their target price on shares of CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 3rd. Finally, Barclays lifted their target price on shares of CME Group from $191.00 to $197.00 and gave the stock an “overweight” rating in a research note on Thursday, May 23rd. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $194.00.

In related news, insider Kathleen M. Cronin sold 4,960 shares of the business’s stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $186.69, for a total value of $925,982.40. Following the sale, the insider now directly owns 49,337 shares in the company, valued at approximately $9,210,724.53. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Elizabeth A. Cook sold 300 shares of the business’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $204.27, for a total transaction of $61,281.00. Following the completion of the sale, the director now owns 20,821 shares in the company, valued at $4,253,105.67. The disclosure for this sale can be found here. In the last three months, insiders have sold 82,363 shares of company stock worth $16,429,225. Corporate insiders own 1.20% of the company’s stock.

Shares of CME stock traded up $3.63 on Thursday, hitting $211.98. 697,064 shares of the stock traded hands, compared to its average volume of 1,342,918. The company’s 50-day moving average price is $203.69. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. The company has a market capitalization of $75.78 billion, a PE ratio of 31.08, a PEG ratio of 4.73 and a beta of 0.23. CME Group Inc has a twelve month low of $161.05 and a twelve month high of $216.73.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.01. The firm had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The company’s revenue was up 20.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.74 EPS. As a group, equities research analysts expect that CME Group Inc will post 6.68 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be given a dividend of $0.75 per share. The ex-dividend date is Monday, September 9th. This represents a $3.00 annualized dividend and a dividend yield of 1.42%. CME Group’s payout ratio is 43.99%.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: Why do companies engage in swaps?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.